Descriptor
| Cost Effectiveness | 1 |
| Decision Making | 1 |
| Drug Therapy | 1 |
| Mental Retardation | 1 |
| Models | 1 |
| Quality of Life | 1 |
| Resource Allocation | 1 |
| Seizures | 1 |
| Technological Advancement | 1 |
Source
| Mental Retardation | 1 |
Author
| Kastner, Theodore A. | 1 |
Publication Type
| Journal Articles | 1 |
| Opinion Papers | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewedKastner, Theodore A. – Mental Retardation, 1997
This commentary on a study comparing use of the brand name drug Depakene with generic valproic acid to control seizures in people with mental retardation focuses on issues of cost-effectiveness. It notes existing guidelines for pharmacoeconomic evaluation and suggests a possible model to include a threshold price (per quality-adjusted life year)…
Descriptors: Cost Effectiveness, Decision Making, Drug Therapy, Mental Retardation
